| List of Cases | International Business (English Language) 3k. | Presentations submission timeliness, slide quality, oratorical art, audience involvement in the case study 0-3 | The complexity of the analyzed problem 0-3 | Case studies breadth, i.e. quite a lot of work done 0-4 | Depth of the case analysis, i.e. use sophisticated analytical techniques 0-4 | It was collected an additional, interesting and valuable material on the Internet 0-2 | A summary of the findings, what is memorable, the most valuable of the case presented, where you can apply the acquired knowledge 0-2 | Working as opponent of the peer presentations or active participation in the cases analysis 0-1. Good questions or comments prized pluses, 3-4 pluses equal to 1 point. | ||||||||
| # | Page | Case | The names of students who analyzed the case | Date of presentation | Presentations queue | Slides of the presentation | Additional material 1 | Additional material 2 | Assessment of case study | |||||||
| 1 | 365-369 | Valuing Capital investment Projects | 0 | |||||||||||||
| 365-369 | Valuing Capital investment Projects | 0 | ||||||||||||||
| 2 | 365-369 | Valuing Capital investment Projects | 0 | |||||||||||||
| 3 | 371-376 | Merck & Company: Evaluating a Drug Licensing Opportunity | Augustinas Janutaitis | 2021-05-06 | 5 | 9 | 2 | 3 | 2 | 1 | 1 | |||||
| 4 | 371-376 | Merck & Company: Evaluating a Drug Licensing Opportunity | Dovydas Stasytis | 2021-05-06 | 5 | 10 | 2 | 3 | 2 | 1 | 1 | 1 | ||||
| 371-376 | Merck & Company: Evaluating a Drug Licensing Opportunity | Aušrinė Šapkaitė | 2021-05-06 | 5 | 9 | 2 | 3 | 2 | 1 | 1 | ||||||
| 5 | 377-379 | Tree Values | 9 | 2 | 3 | 2 | 1 | 1 | ||||||||
| 6 | 377-379 | Tree Values | 9 | 2 | 3 | 2 | 1 | 1 | ||||||||
| 377-379 | Tree Values | 9 | 2 | 3 | 2 | 1 | 1 | |||||||||
| 7 | 381-394 | The Super Project | 0 | |||||||||||||
| 8 | 381-394 | The Super project | 0 | |||||||||||||
| 381-394 | The Super project | 0 | ||||||||||||||
| 9 | 395-403 | Net Flix | Tigran Avagyan | 2021-05-06 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | ||||
| 10 | 395-403 | Net Flix | Ričardas Granickas | 2021-05-06 | 1 | 9 | 3 | 2 | 2 | 1 | 1 | |||||
| 395-403 | Net Flix | Artūras Maciunskas | 2021-05-06 | 1 | 10 | 3 | 2 | 2 | 1 | 1 | 1 | |||||
| 395-403 | Net Flix | Murauskaitė Gintarė | 2021-05-06 | 2 | 8 | 2 | 2 | 2 | 1 | 1 | ||||||
| 395-404 | Net Flix | Pulokaitė Gabija | 2021-05-06 | 2 | 8 | 2 | 2 | 2 | 1 | 1 | ||||||
| 395-403 | Net Flix | Dilinikaitytė Ieva Patricija | 2021-05-06 | 2 | 8 | 2 | 2 | 2 | 1 | 1 | ||||||
| 11 | 405-418 | A-Rod: Signing the Best Player in Baseball | 0 | |||||||||||||
| 405-418 | A-Rod: Signing the Best Player in Baseball | 0 | ||||||||||||||
| 405-418 | A-Rod: Signing the Best Player in Baseball | 0 | ||||||||||||||
| 12 | 405-418 | A-Rod: Signing the Best Player in Baseball | 0 | |||||||||||||
| 405-418 | A-Rod: Signing the Best Player in Baseball | 0 | ||||||||||||||
| 13 | 419-423 | Ocean Carriers | 0 | |||||||||||||
| 14 | 419-423 | Ocean Carriers | 0 | |||||||||||||
| 419-423 | Ocean Carriers | 0 | ||||||||||||||
| 15 | 405-418 | Whirlpool Europe | Duvillard Marie | 0 | ||||||||||||
| 16 | 405-418 | Whirlpool Europe | Bétend Romane | 0 | ||||||||||||
| 405-418 | Whirlpool Europe | Évaux Baptistee | 0 | |||||||||||||
| 405-418 | Whirlpool Europe | 0 | ||||||||||||||
| 17 | 431-434 | Health Development Corporation | 0 | |||||||||||||
| 18 | 431-435 | Health Development Corporation | 0 | |||||||||||||
| 19 | 431-436 | Health Development Corporation | 0 | |||||||||||||
| 20 | 431-437 | Health Development Corporation | 0 | |||||||||||||
| 21 | 431-438 | Health Development Corporation | 0 | |||||||||||||
| 22 | 431-439 | Health Development Corporation | 0 | |||||||||||||
| 23 | 431-440 | Health Development Corporation | 0 | |||||||||||||
| 24 | 431-441 | Health Development Corporation | 0 | |||||||||||||
| 25 | 431-442 | Health Development Corporation | 0 | |||||||||||||
| 18 | 431-443 | Health Development Corporation | 0 | |||||||||||||
| 19 | 257 | The Investment Detective (Investment criteria and discounted cash flow) | Evilė Raupelytė | 2021-05-06 | 7 | 10 | 2 | 2 | 3 | 1 | 1 | 1 | ||||
| 20 | 257 | The Investment Detective (Investment criteria and discounted cash flow) | Aistė Prialgauskaitė | 2021-05-06 | 7 | 10 | 2 | 2 | 3 | 1 | 1 | 1 | ||||
| 21 | 257 | The Investment Detective (Investment criteria and discounted cash flow) | 0 | |||||||||||||
| 257 | The Investment Detective (Investment criteria and discounted cash flow) | 0 | ||||||||||||||
| 22 | 259 | Worldwide Paper Company (Analysis of an expansion investment) | 0 | |||||||||||||
| 23 | 259 | Worldwide Paper Company (Analysis of an expansion investment) | 0 | |||||||||||||
| 24 | 259 | Worldwide Paper Company (Analysis of an expansion investment) | 0 | |||||||||||||
| 25 | 263 | Target Corporation (Multifaceted capital investment decisions) | Ieva Skirkevičiūtė | 2021-05-06 | 4 | 10 | 2 | 2 | 3 | 1 | 1 | 1 | ||||
| 26 | 263 | Target Corporation (Multifaceted capital investment decisions) | Milda Milaknytė | 2021-05-06 | 4 | 10 | 2 | 2 | 3 | 1 | 1 | 1 | ||||
| 27 | 263 | Target Corporation (Multifaceted capital investment decisions) | Domantė Janulytė | 2021-05-06 | 4 | 10 | 2 | 2 | 3 | 1 | 1 | 1 | ||||
| 28 | 283 | Aurora Textile Company (Analysis of an automation investment) | Arif Emre Demir | 2021-05-06 | 6 | 8 | 2 | 2 | 2 | 1 | 1 | |||||
| 29 | 283 | Aurora Textile Company (Analysis of an automation investment) | Zhengli Jin | 2021-05-06 | 6 | 9 | 2 | 2 | 2 | 1 | 1 | 1 | ||||
| 30 | 283 | Aurora Textile Company (Analysis of an automation investment) | Refikcan Korkmaz | 2021-05-06 | 6 | 8 | 2 | 2 | 2 | 1 | 1 | |||||
| 31 | 295 | Compass Records (Analysis of working capital investment) | 0 | |||||||||||||
| 32 | 295 | Compass Records (Analysis of working capital investment) | 0 | |||||||||||||
| 33 | 295 | Compass Records (Analysis of working capital investment) | 0 | |||||||||||||
| 34 | 309 | Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) | 0 | |||||||||||||
| 35 | 309 | Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) | 0 | |||||||||||||
| 36 | 309 | Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) | 0 | |||||||||||||
| 37 | 317 | Victoria Chemicals plc (B): Merseyside and Rotterdam Projects (Mutually exclusive investment opportunities) | Agnė Sukackaitė, | 2021-05-06 | 3 | 9 | 2 | 2 | 2 | 1 | 2 | |||||
| 38 | 317 | Victoria Chemicals plc (B): Merseyside and Rotterdam Projects (Mutually exclusive investment opportunities) | Aistė Sedlevičiūtė | 2021-05-06 | 3 | 9 | 2 | 2 | 2 | 1 | 2 | |||||
| 39 | 317 | Victoria Chemicals plc (B): Merseyside and Rotterdam Projects (Mutually exclusive investment opportunities) | Aušrinė Krūminytė. | 2021-05-06 | 3 | 9 | 2 | 2 | 2 | 1 | 2 | |||||
| 40 | 325 | Euroland Foods S.A. (Strategic resource allocation) | 0 | |||||||||||||
| 41 | 325 | Euroland Foods S.A. (Strategic resource allocation) | 0 | |||||||||||||
| 42 | 325 | Euroland Foods S.A. (Strategic resource allocation) | 0 | |||||||||||||
| 325 | Euroland Foods S.A. (Strategic resource allocation) | |||||||||||||||
| 43 | 337 | Star River Electronics Ltd.(Capital project analysis and forecasting) | 0 | |||||||||||||
| 44 | 337 | Star River Electronics Ltd.(Capital project analysis and forecasting) | 0 | |||||||||||||
| 45 | 337 | Star River Electronics Ltd.(Capital project analysis and forecasting) | 0 | |||||||||||||
| 46 | 0 | |||||||||||||||
| 47 | 0 | |||||||||||||||
| 48 | 0 | |||||||||||||||